Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5% minoxidil and early excessive shedding in androgenetic alopecia
ChiCTR2200058578Phase 4Recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of minoxidil in androgenetic alopecia (AGA), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoints: amount of hair loss, duration of hair loss and 2 more. Started Aug 2021; status: recruiting.
02
Drugs
minoxidil
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on ChiCTR2200058578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200058578.